Liquid Biopsy News and reporting on cell-free DNA testing. Sep 12, 2022 ESMO Data Sharpens View of How Grail, Exact Sciences Multi-Cancer Early Detection Tests Perform Premium Sep 7, 2022 Larger Liquid Biopsy Panels Loom, But Patient Benefit Still Uncertain Premium Sep 6, 2022 Freenome Launches Multi-Cancer Detection Study Using Multiomics, Real-World Evidence Sep 6, 2022 EU to Disallow Illumina's Grail Purchase Sep 1, 2022 Illumina Says Judge Issued Favorable Decision in FTC Challenge to Grail Acquisition Aug 30, 2022 Thermo Fisher Scientific Obtains CE-IVD Mark for Targeted NGS Oncology Test, Analysis Software Aug 18, 2022 Personalis Adds Newly Issued Patent to Foresight Diagnostics Infringement Suit Aug 16, 2022 Extracellular Vesicles Show Promise as Early-Stage Liver Cancer Diagnostic Premium Aug 12, 2022 Guardant Health, Thermo Fisher Scientific Tests Approved as CDx to Enhertu in Lung Cancer Aug 10, 2022 VolitionRx, MD Anderson Cancer Center Partner to Study Cancer Patients With Sepsis Aug 9, 2022 Predicine Receives CE-IVD Mark for Blood and Urine Liquid Biopsy Assay Aug 8, 2022 Harbinger Health Joins Emerging Multi-Cancer Screening Arena With Tech Focused On Oncogenesis Premium Aug 8, 2022 VolitionRx Signs on Diagnostic Oncology CRO for Clinical Studies of Cancer, Sepsis Tests Aug 3, 2022 Exact Sciences Partners With West German Study Group to Validate MRD Test in Breast Cancer Aug 3, 2022 VolitionRx Secures $1.5M Loan From Namur Invest Capital Risk Aug 2, 2022 Personalis Sues Foresight Diagnostics, Alleging Patent Infringement Aug 2, 2022 Guardant Health Receives Medicare Coverage for MRD Liquid Biopsy in Stage II and III Colon Cancer Jul 22, 2022 Lung Cancer MRD Study Bolsters Validity Evidence, Suggests Longitudinal Test Cutoff Premium Jul 21, 2022 Imagia Canexia Health, Anwa Medical Partner to Offer Liquid Biopsy in Middle East, North Africa Jul 15, 2022 4D Lifetec Raises $1.9M in Series B Financing to Support Lung Cancer Detection Test Launch Load More Breaking News Rady Children's, PlumCare RWE Partner to Expand WGS-Based Newborn Screening Program to Greece Roche Gets CE Mark for New Version of Rapid Test for Antibodies Against SARS-CoV-2 Broader Market Drags 360Dx Top 30 Down in September Olive Diagnostics Nabs CE Mark for Optical Urinalysis Device Top Five Articles on 360Dx Last Week: Congress and VALID Act; FDA Updates EUA Policy; and More In Brief This Week: Becton Dickinson, Bionano, Yourgene, More What's Popular? In Liquid Biopsy Larger Liquid Biopsy Panels Loom, But Patient Benefit Still Uncertain Premium Guardant Health Receives Medicare Coverage for MRD Liquid Biopsy in Stage II and III Colon Cancer Guardant Health, Thermo Fisher Scientific Tests Approved as CDx to Enhertu in Lung Cancer
